Ameritas Investment Partners’s Acorda Therapeutics ACOR Stock Holding History

Ameritas Investment Partners’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-31	Closed	-$3K	–	3170
2020 Q1	$3K	Hold	31	–	–	﹤0.01%	2938
2019 Q4	$8K	Hold	31	–	–	﹤0.01%	2820
2019 Q3	$11K	Hold	31	–	–	﹤0.01%	2722
2019 Q2	$28K	Hold	31	–	–	﹤0.01%	2252
2019 Q1	$49K	Hold	31	–	–	﹤0.01%	1899
2018 Q4	$58K	Hold	31	–	–	﹤0.01%	1719
2018 Q3	$73K	Hold	31	–	–	﹤0.01%	1760
2018 Q2	$107K	Hold	31	–	–	0.01%	1509
2018 Q1	$88K	Hold	31	–	–	﹤0.01%	1574
2017 Q4	$80K	Hold	31	–	–	﹤0.01%	1638
2017 Q3	$77K	Hold	31	–	–	﹤0.01%	1620
2017 Q2	$73K	Hold	31	–	–	﹤0.01%	1659
2017 Q1	$78K	Buy	+31	New	+$89.2K	﹤0.01%	1572
2015 Q2	–	Sell	-123	Closed	-$492K	–	1225
2015 Q1	$492K	Buy	+123	New	+$563K	0.03%	616

Other funds holding ACOR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameritas Investment Partners's ACOR Position: Q2 2020 in Review

Ameritas Investment Partners sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 31 shares — an estimated $3K sold.

Ameritas Investment Partners first reported a position in ACOR in Q1 2015 and held it in 14 quarters. The position peaked at $492K in Q1 2015. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

Ameritas Investment Partners reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
Ameritas Investment Partners sold 31 Acorda Therapeutics shares in Q2 2020, an estimated $3K.
Ameritas Investment Partners first reported a position in Acorda Therapeutics in Q1 2015 and held it in 14 quarters.
Ameritas Investment Partners's Acorda Therapeutics position peaked at $492K in Q1 2015.
79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Ameritas Investment Partners's 13F filing for Q2 2020, filed 5 Aug 2020.